126 related articles for article (PubMed ID: 16053517)
1. Inhibitory effect of a selective cyclooxygenase inhibitor on the invasion-stimulating activity of orthotopic fibroblasts for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Hirakawa K
Cancer Sci; 2005 Jul; 96(7):451-5. PubMed ID: 16053517
[TBL] [Abstract][Full Text] [Related]
2. Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
Yashiro M; Nakazawa K; Tendo M; Kosaka K; Shinto O; Hirakawa K
Int J Cancer; 2007 Feb; 120(3):686-93. PubMed ID: 17096355
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.
Inoue T; Chung YS; Yashiro M; Nishimura S; Hasuma T; Otani S; Sowa M
Jpn J Cancer Res; 1997 Feb; 88(2):152-9. PubMed ID: 9119743
[TBL] [Abstract][Full Text] [Related]
4. Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth of scirrhous gastric cancer.
Yashiro M; Chung YS; Sowa M
Anticancer Res; 1997; 17(2A):895-900. PubMed ID: 9137424
[TBL] [Abstract][Full Text] [Related]
5. A synergic inhibitory-effect of combination with selective cyclooxygenase-2 inhibitor and S-1 on the peritoneal metastasis for scirrhous gastric cancer cells.
Tendo M; Yashiro M; Nakazawa K; Yamada N; Sawada T; Ohira M; Hirakawa K
Cancer Lett; 2006 Dec; 244(2):247-51. PubMed ID: 16448745
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
Uefuji K; Ichikura T; Shinomiya N; Mochizuki H
Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258
[TBL] [Abstract][Full Text] [Related]
7. Paracrine activation of MET promotes peritoneal carcinomatosis in scirrhous gastric cancer.
Zhao L; Yasumoto K; Kawashima A; Nakagawa T; Takeuchi S; Yamada T; Matsumoto K; Yonekura K; Yoshie O; Yano S
Cancer Sci; 2013 Dec; 104(12):1640-6. PubMed ID: 24118504
[TBL] [Abstract][Full Text] [Related]
8. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T
J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.
Mizutani Y; Kamoi K; Ukimura O; Kawauchi A; Miki T
J Urol; 2002 Dec; 168(6):2650-4. PubMed ID: 12442003
[TBL] [Abstract][Full Text] [Related]
10. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
[TBL] [Abstract][Full Text] [Related]
12. JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.
Wakitani K; Tazaki H; Matsushita M; Iwamura H
Inflamm Res; 2000 Mar; 49(3):117-22. PubMed ID: 10807499
[TBL] [Abstract][Full Text] [Related]
13. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
14. Tranilast (N-3,4-dimethoxycinamoyl anthranilic acid): a novel inhibitor of invasion-stimulating interaction between gastric cancer cells and orthotopic fibroblasts.
Yashiro M; Murahashi K; Matsuoka T; Nakazawa K; Tanaka H; Osaka H; Koyama T; Ohira M; Chung KH
Anticancer Res; 2003; 23(5A):3899-904. PubMed ID: 14666694
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
16. Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Cancer Sci; 2010 Aug; 101(8):1846-52. PubMed ID: 20518790
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma.
Nakazawa K; Yashiro M; Hirakawa K
Cancer Res; 2003 Dec; 63(24):8848-52. PubMed ID: 14695201
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a New Scirrhous Gastric Cancer Cell Line with FGFR2 Overexpression, OCUM-14.
Okuno T; Yashiro M; Masuda G; Togano S; Kuroda K; Miki Y; Hirakawa K; Ohsawa M; Wanibuchi H; Ohira M
Ann Surg Oncol; 2019 Apr; 26(4):1093-1102. PubMed ID: 30652228
[TBL] [Abstract][Full Text] [Related]
20. Differential responses of scirrhous and well-differentiated gastric cancer cells to orthotopic fibroblasts.
Yashiro M; Chung YS; Kubo T; Hato F; Sowa M
Br J Cancer; 1996 Oct; 74(7):1096-103. PubMed ID: 8855981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
